SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000891293-20-000045
Filing Date
2020-06-19
Accepted
2020-06-19 16:27:08
Documents
4
Effectiveness Date
2020-06-19
Reference 429
333-231708

Document Format Files

Seq Description Document Type Size
1 S-8 cti-formsx8xjune2020.htm S-8 55488
2 EXHIBIT 4.4 exhibit44.htm EX-1 9885
3 EXHIBIT 5.1 exhibit51.htm EX-2 7229
4 EXHIBIT 23.2 exhibit232.htm EX-3 2358
  Complete submission text file 0000891293-20-000045.txt   76117
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239311 | Film No.: 20975954
SIC: 2834 Pharmaceutical Preparations